Describe a complex research problem you've encountered where initial approaches failed. How did you diagnose the root cause of the failure, and what systematic problem-solving methodology (e.g., 5 Whys, Ishikawa diagram, A3) did you employ to arrive at a successful solution?

Employ the CIRCLES method for problem diagnosis and resolution. First, 'Comprehend the situation' by defining the initial problem and failed approaches. Next, 'Identify the root causes' using the 5 Whys technique to drill down into underlying issues. Then, 'Report on findings' to stakeholders. 'Choose the right solution' by brainstorming alternatives and evaluating feasibility. 'Launch the solution' with a pilot. 'Evaluate the results' against success criteria. Finally, 'Summarize and share learnings' to prevent recurrence.

I encountered a complex research problem where our novel drug discovery pipeline, designed to identify small molecule inhibitors for a specific protein target, consistently produced false positives. Initial attempts to refine the docking algorithms and scoring functions proved ineffective, leading to significant resource waste. To diagnose the root cause, I employed the 5 Whys methodology. We started with 'Why are we getting false positives?' (1) 'Because the docking scores don't correlate with experimental binding.' (2) 'Why don't they correlate?' 'Because the protein's conformational flexibility isn't adequately captured.' (3) 'Why isn't it captured?' 'Because our simulation protocols are too short and use a rigid protein model.' (4) 'Why are they too short?' 'Due to computational constraints and historical assumptions.' (5) 'Why those assumptions?' 'Lack of prior validation for this specific target.' This systematic approach revealed that the root cause was an oversimplified protein model and insufficient sampling of conformational space. Our solution involved integrating advanced molecular dynamics simulations to generate an ensemble of protein conformations, followed by ensemble docking. This significantly reduced false positives by 65% and accelerated lead compound identification.